If you need more lookups,
subscriptions start at $34 USD/month.
Lan Chen Location
Japan
Lan Chen Work
TA ONC Lead JP, Senior Director @ (July 2024 - Present)
R and D Clinical Science Head @ (February 2024 - August 2024)
R and D CS ONC Head @ (May 2023 - August 2024)
Corporate TA ONC Asset Lead @ (September 2021 - April 2023)
Head of Specialty Care Medicine @ (April 2020 - September 2021)
TA Oncology Head @ (March 2019 - March 2020)
Medical Director for R and D @ Merck Serono (July 2016 - February 2019)
Medical director for R and D @ (January 2013 - June 2016)
Medical Affairs Manager @ (April 2011 - December 2012)
Senior Scientist @ (April 2007 - March 2011)
International Researcher @ Nagoya Univ. medical school (April 2002 - March 2003)
Resident @ Liaohe Petroleum Central Hospital (July 1999 - March 2002)
Lan Chen Education
King's College London, U. of London
(Clinical Pharmacology)
2011-2013
Nagoya Univ. Medical School
Ph.D (Molecular Biology)
2003-2007
China Medical University
M.D. (Clinical Medicine)
1994-1999
Lan Chen Skills
Medical Affairs
Cancer
Medicine
Clinical Development
Pharmacovigilance
Clinical Trials
Oncology
Pharmaceutical Industry
Clinical Research
Medical Education
Biochemistry
Social Media
Outlook
Public Speaking
Microsoft Word
Windows
Lan Chen Summary
Lan Chen, based in Japan, is currently a TA ONC Lead JP, Senior Director at Johnson & Johnson Innovative Medicine. Lan Chen brings experience from previous roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and Boehringer Ingelheim. Lan Chen holds a 2011 - 2013 King's College London, U. of London. With a robust skill set that includes Medical Affairs, Cancer, Medicine, Clinical Development, Pharmacovigilance and more. Lan Chen has 2 emails on RocketReach.
Looking for a different Lan Chen?
Find contact details for 700 million professionals.